HCA Healthcare Amends 8-K Filing on Officer Compensation

Ticker: HCA · Form: 8-K/A · Filed: Feb 26, 2024 · CIK: 860730

Sentiment: neutral

Topics: amendment, corporate-governance, executive-compensation

Related Tickers: HCA

TL;DR

**HCA Healthcare just amended an 8-K about executive changes and pay, so keep an eye on leadership and compensation details.**

AI Summary

HCA Healthcare, Inc. filed an 8-K/A on February 26, 2024, amending a previous report from January 24, 2024. The amendment pertains to Item 5.02, specifically regarding the departure or election of directors or certain officers and their compensatory arrangements. The filing updates information for the company, which is incorporated in Delaware and has its business address at One Park Plaza, Nashville, Tennessee.

Why It Matters

This amendment provides updated information on executive changes and compensation, which can influence investor perception of corporate governance and financial stability.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, indicating a clarification or update rather than a new, unexpected event.

Key Players & Entities

FAQ

What is the purpose of this 8-K/A filing by HCA Healthcare, Inc.?

The 8-K/A filing by HCA Healthcare, Inc. is an amendment (Amendment No. 1) to a previous Current Report on Form 8-K, specifically addressing Item 5.02 regarding the departure or election of directors or certain officers and their compensatory arrangements.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on January 24, 2024.

What is the filing date of this 8-K/A?

The filing date of this 8-K/A is February 26, 2024.

Where is HCA Healthcare, Inc. incorporated?

HCA Healthcare, Inc. is incorporated in Delaware.

What is the business address of HCA Healthcare, Inc.?

The business address of HCA Healthcare, Inc. is One Park Plaza, Nashville, Tennessee.

Filing Stats: 753 words · 3 min read · ~3 pages · Grade level 11.7 · Accepted 2024-02-26 16:35:04

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCA HEALTHCARE, INC. /s/ John M. Franck II John M. Franck II Vice President - Legal and Corporate Secretary Date: February 26, 2024

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing